No reviews yet.
This Health Industry Insights report identifies what types of commercial IT applications and services large pharmaceutical companies are looking to outsource over the next 12-24 months. Patent expirations and vulnerable drug pipelines have driven pharmaceutical companies to spend most of this decade reducing overhead and reassessing what is operationally outsource worthy versus strategically core. This book may contain less than 24 pages of technical content.